BCS1L
protein-codingBCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone, the group of Mitochondrial respiratory chain complex assembly factors|AAA ATPases
Gene summary
This gene encodes a homolog of the S. cerevisiae bcs1 protein which is involved in the assembly of complex III of the mitochondrial respiratory chain. The encoded protein does not contain a mitochondrial targeting sequence but experimental studies confirm that it is imported into mitochondria. Mutations in this gene are associated with mitochondrial complex III deficiency and the GRACILE syndrome. Several alternatively spliced transcripts encoding two different isoforms have been described. [provided by RefSeq, Jan 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~4.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009872
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0007415
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009872
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011308
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009872
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0015448
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0016811
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0009872
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *BCS1L* and *BCS1L*-related primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of September 19, 2024. The *BCS1L* gene encodes a complex III assembly factor presumed to facilitate insertion of Rieske Fe/S proteins. The *BCS1L* gene was first reported in relation to autosomal recessive *BCS1L*-related primary mitochondrial disease in 2002 (PMID: 12215968). *BCS1L* has been associated with three disease entities to date; Bjornstad syndrome (characterized by sensorineural hearing loss, pili torti, and hypotrichosis) [OMIM# 262000]; growth restriction, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death (GRACILE) syndrome [OMIM# 603358]; and mitochondrial complex III deficiency, nuclear type 1 [OMIM# 124000]. This is one disease entity according to the ClinGen Lumping and Splitting Framework, and has been renamed as *BCS1L*-related primary mitochondrial disease. Of note, *BCS1L* was first curated by this Expert Panel for its association with Leigh syndrome spectrum (LSS) on September 9, 2019 (SOP v7), with a final classification of Limited. This current curation for the association with *BCS1L*-related primary mitochondrial disease includes cases with LSS. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 17 unique variants (12 missense, four premature truncation, one synonymous variant shown to impact splicing) identified in nine unrelated cases from eight publications (PMIDs: 17403714, 20472482, 25895478, 31435670, 35960161, 34650211, 28105683, 34662929), although more affected individuals have been reported to date (PMID: 34662929). While some reported individuals have features consistent with one of the three clinical syndromes reported to be associated with *BCS1L*, it is now known that these features occur on a spectrum and include LSS, developmental regression, seizures, exercise intolerance, growth restriction, short stature, failure to thrive, decreased liver function, cholestasis, optic atrophy, sensorineural hearing loss, pili torti, hypotrichosis, renal tubulopathy, and metabolic acidosis. Cerebral and cerebellar atrophy and thalamic and basal ganglia involvement can be seen on brain imaging. Ragged red fibers and complex III deficiency are seen in skeletal muscle. The mechanism of disease is loss of function. This gene-disease relationship is also supported by the known protein interaction with complex III subunits and assembly factors (PMIDs: 17314340, 30030361, 24466228), functional alteration studies in patient cells showing evidence of complex III deficiency (PMIDs: 17314340, 28427446), and model systems including fruit fly, mouse, and yeast (PMIDs: 34274978, 22829922, 21274865, 17314340). In summary, there is definitive evidence to support the relationship between *BCS1L* and autosomal recessive *BCS1L*-related primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 19, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0007415
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between BCS1L and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of September 9, 2019. Variants in BCS1L were first reported in humans with Leigh syndrome spectrum in 2001 (PMID: 11528392). Several pathogenic variants have been reported in ClinVar, and loss of function is the mechanism of disease for this gene. Evidence supporting this gene-disease relationship includes case-level data and experimental data. One proband with BCS1L a homozygous pathogenic variant with Leigh syndrome spectrum has been reported in the 2001 publication (PMID: 11528392) to reach a case-level evidence score of 1.5. This gene-disease association is further supported by BCS1L protein interaction with other genes associated with Leigh syndrome spectrum, BCS1L expression in brain, mitochondrial alterations in patient cell lines, and a BCS1L mouse model exhibiting a neuropathological, biochemical, and developmental phenotype that recapitulates symptoms of Leigh syndrome spectrum reaching a experimental score of 5 pts. In summary, there is limited evidence to support the relationship between BCS1L and autosomal recessive Leigh syndrome spectrum. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 9, 2019 (SOP Version 7).
Inheritance Pattern: AR
Disease ID:MONDO:0011308
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009872
Submitter: ClinGen
The BCS1L gene has been associated with autosomal recessive Bjornstad syndrome using the ClinGen Clinical Validity Framework as of 12/13/16. This association was made using case-level data only. At least 12 missense, splice site, and frameshift variants have been reported in humans. BCS1L was first associated with this disease in humans as early as 2007 (Hinson et al.). Association is seen in at least 9 probands in 5 publications (17314340, 24172246, 25895478, 28322498, 28105683). Variants in this gene segregated with disease in 13 additional family members. This gene-disease association is supported by experimental evidence performed by Hinston et al. 2007. In summary, BCS1L is definitively associated with autosomal recessive Bjornstad syndrome. This classification was approved by the ClinGen Hearing Loss Working Group on 7/9/18.
Inheritance Pattern: AR
Disease ID:MONDO:0007415
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009872
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011308
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011308
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0007415
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Biochemical; Dermatologic; Gastrointestinal; Genitourinary; Neurologic; Ophthalmologic; Renal
Intervention: Audiologic/Otolaryngologic; Biochemical
Rationale: In Bjornstad syndrome, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; It has been suggested that that stapes surgery should not be performed due to a high likelihood of complications (the use of cochlear implants has been reported as beneficial); In Mitochondrial complex III deficiency, nuclear, some treatment attempts (eg, with apotransferrin) have been reported, and treatment with mitochondrial cocktail type therapy may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BCS1L variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001079866.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 5 | 189 | 196 | ||
| missense | 11 | 33 | 128 | 8 | 1 | 181 |
| nonsense | 8 | 29 | 37 | |||
| start loss | 2 | 1 | 3 | |||
| frameshift | 21 | 35 | 1 | 57 | ||
| splice donor/acceptor (+/-2bp) | 2 | 13 | 8 | 23 | ||
| Total | 44 | 113 | 142 | 197 | 1 | 497 |
Highest pathogenic variant AF is 0.00026948866
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001073335.1 | 7 | MANE Select | |
| Ensembl | ENSP00000352219.3 | 7 | MANE Select | |
| RefSeq | NP_001244271.1 | 7 | Standard | |
| RefSeq | NP_001244272.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of proteins
- Mitochondrial protein import
Biological Process
- mitochondrion organization
- mitochondrial respiratory chain complex I assembly
- mitochondrial respiratory chain complex IV assembly
- mitochondrial respiratory chain complex III assembly
Molecular Function
- protein binding
- ATP binding
Cellular Component
- mitochondrion
- mitochondrial respiratory chain complex III
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000431802
- Coding exons
- 7
- Length
- 4680
- Individuals with no LoFs
- 125614
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 134
- Defined
- 125748
- p
- 0.000533
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.62 | 170 | 241 | 0.707 | 0.0000159 | 2705 |
| Missense (PolyPhen) | 62 | 106.85 | 0.58024 | 1144 | ||
| Synonymous | -0.481 | 100 | 94.1 | 1.06 | 0.00000574 | 890 |
| Loss of Function | 0.647 | 21 | 24.5 | 0.859 | 0.00000199 | 201 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00069 | 0.00069 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00038 | 0.00038 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00068 | 0.00068 | rare |
| South Asian | 0.00052 | 0.00052 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Chaperone necessary for the assembly of mitochondrial respiratory chain complex III. Plays an important role in the maintenance of mitochondrial tubular networks, respiratory chain assembly and formation of the LETM1 complex. {ECO:0000269|PubMed:18628306}.;
- Disease
- DISEASE: Mitochondrial complex III deficiency, nuclear 1 (MC3DN1) [MIM:124000]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:11528392, ECO:0000269|PubMed:12910490, ECO:0000269|PubMed:17314340, ECO:0000269|PubMed:17403714, ECO:0000269|PubMed:18628306, ECO:0000269|PubMed:19162478, ECO:0000269|PubMed:22991165}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bjoernstad syndrome (BJS) [MIM:262000]: An autosomal recessive disease characterized by congenital sensorineural hearing loss and twisted hairs (pili torti). Pili torti is a condition in which the hair shafts are flattened at irregular intervals and twisted 180 degrees from the normal axis, making the hair extremely brittle. {ECO:0000269|PubMed:17314340, ECO:0000269|PubMed:24172246}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.654
Intolerance Scores
- LoFtool
- 0.170
- RVIS EVS
- -0.62
- RVIS percentile EVS
- 17.16
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.917
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |